Use of megavoltage computed tomography with image registration for high-dose rate treatment planning of an oral tongue cancer using a custom oral mold applicator with embedded lead shielding

被引:4
|
作者
Libby, Bruce [1 ]
Sheng, Ke [1 ]
McLawhorn, Robert [1 ]
McIntosh, Alyson [1 ]
Van Ausdal, Ray G. [1 ]
Martof, Andrew [2 ]
Read, Paul [1 ]
机构
[1] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Dent, Charlottesville, VA 22908 USA
关键词
High-dose rate brachytherapy; MVCT; Image registration; Acuros; GINGIVAL CARCINOMA; RATE BRACHYTHERAPY; DOSIMETRY; IMPLANT;
D O I
10.1016/j.brachy.2011.01.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: A patient with a lateral oral tongue cancer was treated with high-dose rate brachytherapy using an oral applicator with embedded lead shielding making conventional simulation, using either kilovoltage computed tomography or radiographs, impossible because of scatter artifact. METHODS AND MATERIALS: Treatment simulation was accomplished using megavoltage computed tomography (MVCT) simulation on a helical tomotherapy unit. Because of difficulty in visualization of the catheters on the patient MVCT images, Velocity AI image registration software (Velocity Medical Solutions, Atlanta, GA) was used to register an MVCT of the applicator itself with the patient MVCT simulation. The treatment plan was manually optimized to prescribe 4 Gy/fraction to the gross tumor volume. RESULTS: The patient tolerated the treatment well, with no evidence of disease 6 months after treatment. Thermoluminescent dosimeter measurements showed that the shielding reduced the dose by up to 90%, depending on the location of the thermoluminescent dosimeter. While the patient was treated using dose distributions calculated in a homogeneous medium (Task Group-43), an approximation of the true dose distributions was retrospectively calculated using Acuros (Varian Medical Systems Inc., Palo Alto, CA), which accounts for heterogeneities in the patient. DISCUSSION: Use of the MVCT with image registration allowed treatment planning in the presence of lead shielding. Dose-volume histograms showed that recalculation of the dose using heterogeneity correction did not affect the dose to the gross tumor volume, but that the dose to normal structures (maxilla and mandible) was reduced by the lead shielding. CONCLUSION: The use of MVCT and image registration allows for optimized planning in the presence of shielding, which would not be possible with conventional kilovoltage computed tomography. (C) 2011 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:340 / 344
页数:5
相关论文
共 4 条
  • [1] Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer
    Tucek, Lubos
    Petera, Jiri
    Sirak, Igor
    Vosmik, Milan
    Dolezalova, Helena
    Brokesova, Simona
    Hodek, Miroslav
    Kasaova, Linda
    Paluska, Petr
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2011, 16 (06) : 243 - 247
  • [2] Shielding Effect of a Customized Intraoral Mold Including Lead Material in High-dose-rate 192-Ir Brachytherapy for Oral Cavity Cancer
    Kudoh, Takaharu
    Ikushima, Hitoshi
    Honda, Eiichi
    JOURNAL OF RADIATION RESEARCH, 2012, 53 (01) : 130 - 137
  • [3] Computed tomography-based treatment planning for high-dose-rate brachytherapy using the tandem and ring applicator: influence of applicator choice on organ dose and inter-fraction adaptive planning
    Dumane, Vishruta A.
    Yuan, Yading
    Sheu, Ren-Dih
    Gupta, Vishal
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (03) : 279 - 286
  • [4] Image-guided cervix high-dose-rate brachytherapy treatment planning: Does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson, Melanie T. M.
    Yuen, Jasper
    D'Souza, David P.
    Batchelar, Deidre L.
    BRACHYTHERAPY, 2008, 7 (01) : 37 - 42